| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 06/23/1992 | CA1304025C Modified zein |
| 06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
| 06/23/1992 | CA1304023C .beta.-UROGASTRONE GENE, CORRESPONDING RECOMBINANT PLASMIDS, CORRESPONDING TRANSFORMANTS AND PREPARATION THEREOF AND OF .beta.-UROGASTRONE |
| 06/23/1992 | CA1304022C Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors |
| 06/23/1992 | CA1304021C Microbiological process for the preparation of a protein by culturing a mutant bacterial strain |
| 06/23/1992 | CA1304020C High level expression in yeast |
| 06/22/1992 | WO1992011348A1 Enzymes and enzymatic detergent compositions |
| 06/22/1992 | WO1992011343A1 Microbial process for reduction of petroleum viscosity |
| 06/22/1992 | CA2098836A1 Microbial process for reduction of petroleum viscosity |
| 06/22/1992 | CA2098703A1 Enzymes and enzymatic detergent compositions |
| 06/22/1992 | CA2058280A1 Expression systems |
| 06/22/1992 | CA2058052A1 Slow-release biodegradable granules of pasteuria penetrans |
| 06/20/1992 | WO1992011378A1 A method of constructing synthetic leader sequences |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/20/1992 | CA2098731A1 Method of constructing synthetic leader sequences |
| 06/20/1992 | CA2057715A1 Method for enhancing the structural stability of recombinant dna expression vectors |
| 06/19/1992 | WO1992011377A1 Tissue plasminogen activator substitution variant |
| 06/19/1992 | WO1992011360A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/19/1992 | CA2098484A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 06/19/1992 | CA2057951A1 Chimeric antibodies and their use |
| 06/19/1992 | CA2057842A1 Human monoclonal antibody |
| 06/19/1992 | CA2055572A1 Processes and intermediates for thromboxane receptor antagonists |
| 06/17/1992 | EP0490474A2 Novel avermectins are produced from known microorganisms |
| 06/17/1992 | EP0490410A1 TXA2 Receptor and gene encoding the same |
| 06/17/1992 | EP0489830A1 Expression of alpha-macroglobulins |
| 06/17/1992 | EP0489780A1 Fusion proteins, their preparation and use |
| 06/17/1992 | EP0479922A4 Monoclonal antibodies to c-reactive protein |
| 06/17/1992 | EP0467953A4 Improved primer extension reactions |
| 06/17/1992 | EP0290569B1 Low-temperature active akaline protease from paecilomyces marquandii and its preparation |
| 06/17/1992 | CN1062002A Protease |
| 06/16/1992 | US5122594 Having specific arginines replaced by glutamine and/or serine |
| 06/16/1992 | US5122465 Strains of pichia pastoris created by interlocus recombination |
| 06/16/1992 | US5122464 Method for dominant selection in eucaryotic cells |
| 06/16/1992 | US5122463 Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor |
| 06/16/1992 | US5122458 Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells |
| 06/16/1992 | US5122457 Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase |
| 06/16/1992 | US5122449 Complexing antigen with labeled antibodies; immunoassay |
| 06/16/1992 | CA2057651A1 Agistatins, novel metabolites from fusarium sp., a process for their preparation, and their use |
| 06/16/1992 | CA1303536C Process for producing l-threonine by fermentation |
| 06/16/1992 | CA1303534C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303533C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303531C Choriocarcinoma monoclonal antibodies and antibody panels |
| 06/16/1992 | CA1303529C Human interferon- _polypeptide derivative |
| 06/16/1992 | CA1303483C Microencapsulated insecticidal pathogens |
| 06/14/1992 | WO1992010577A1 Multisite integration cassette for the genome of a yeast |
| 06/14/1992 | WO1992010564A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
| 06/14/1992 | CA2098510A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
| 06/14/1992 | CA2098304A1 Multisite integration cassette for the genome of a yeast |
| 06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |
| 06/11/1992 | WO1992009701A1 Analytical tracers for cancer, particularly malignant breast cancer |
| 06/11/1992 | WO1992009695A1 Structural proteins from artificial genes |
| 06/11/1992 | WO1992009693A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
| 06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
| 06/11/1992 | WO1992009687A1 Precipitation process for exocellular proteins |
| 06/11/1992 | WO1992009629A1 Protein presenting an activity of the cytokine type, recombinant dna, expression vector and hosts used to produce such protein |
| 06/11/1992 | WO1992009617A1 Cell stress transcriptional factors |
| 06/11/1992 | WO1992009305A1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 06/11/1992 | DE4139840A1 Compsns. contg. antigen from cell-associated protein of H. pylorus - useful for sensitive selective detection of antibodies with less false positives and negatives |
| 06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |
| 06/11/1992 | CA2073860A1 Analytical tracers for cancer, particularly malignant breast cancer |
| 06/10/1992 | EP0489718A1 Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
| 06/10/1992 | EP0489711A2 Method for producing human growth hormone |
| 06/10/1992 | EP0489647A2 N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them |
| 06/10/1992 | EP0489258A1 A bio-metallurgical process in which bio-oxidation of mineral compounds is produced |
| 06/10/1992 | EP0489201A1 Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant DNA and transformed microorganisms |
| 06/10/1992 | EP0489113A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
| 06/10/1992 | EP0489062A1 Bone-specific protein |
| 06/10/1992 | EP0425563A4 Process for amplifying and detecting nucleic acid sequences |
| 06/10/1992 | EP0290567B1 Low-temperature active alkaline protease from nocardiopsis dassonvillei and its preparation |
| 06/10/1992 | EP0174367B1 Hosts and methods for producing recombinant products in high yields |
| 06/09/1992 | US5120852 Process for preparing (1r,2r)-2-(3-pyridyl)-tetrahydrothiopyran-2-carbothioamide 1-oxides thereby |
| 06/09/1992 | US5120837 Dna encoding phe a feedback inhibition resistant enzyme analogues |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120658 Thermostable tryptophan synthetase gene and extremely thermophilic plasmid vector incorporating said gene |
| 06/09/1992 | US5120655 Riboflavin producing strains of microorganisms |
| 06/09/1992 | US5120654 Cloning and use of the transaminase gene ilve |
| 06/09/1992 | US5120652 Substantially purified n-acyl-l-proline acylase from comamonas testosteroni dsm 5416 and alcaligenes denitrificans dsm 5417 |
| 06/09/1992 | US5120651 Cleavage of dna sequences;culture product og Agrobacterium |
| 06/09/1992 | US5120647 Phospholipase a2 inhibitor |
| 06/09/1992 | US5120645 Production of 2-deoxyuridine |
| 06/09/1992 | US5120642 Medical diagnosis |
| 06/09/1992 | US5120536 Pure cultures from which crystalline parasporal proteins are obtained |
| 06/09/1992 | CA1302931C Preparation of pyruvic acid |
| 06/09/1992 | CA1302927C Efomycin g, its preparation and its use as a yield promoter in animals |
| 06/09/1992 | CA1302926C Antibiotic f-0769, process for its production, and its use as a growthaccelerating and feed efficiency increasing agent and as an antitumour agent |
| 06/09/1992 | CA1302923C Process for producing 4-androstene -3,17-dione and 1,4-androstardiene -3,17-dione |
| 06/08/1992 | WO1992010571A1 Human dopamine d4 receptor and its uses |
| 06/05/1992 | WO1992010562A1 Ganoderma lucidium iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity |
| 06/04/1992 | WO1992009613A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/04/1992 | CA2097416A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/04/1992 | CA2056878A1 N,o-sulphated heparosans, process for preparing them and pharmaceutical compositions containing them |
| 06/03/1992 | EP0488916A1 Process for enzymatic preparation of ammonium adipate |
| 06/03/1992 | EP0488900A1 Protein with cytokine activity, recombinant DNA, expression vector and hosts for obtaining it |
| 06/03/1992 | EP0488528A1 Recombinant adeno-associated virus vectors |
| 06/03/1992 | EP0488479A1 DNA sequences, recombinant DNA molecules and processes for producing swine growth hormone-like polypeptides |
| 06/03/1992 | EP0488470A1 Method for the production of antibodies |
| 06/03/1992 | EP0488279A2 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
| 06/03/1992 | EP0488277A1 Antibody reactive to hamster immunoglobulins |
| 06/03/1992 | EP0488224A2 Fermentationproduct of a Verticimonosporium strain and feed additivs containing a linear peptide |
| 06/03/1992 | EP0488196A2 HST-2, a member of the heparin binding growth factor family |